Palliative care for people who use drugs during communicable disease epidemics and pandemics: A scoping review on access, policies, and programs and guidelines DOI
Daniel Z. Buchman,

Samantha Lo,

Philip Q. Ding

et al.

Palliative Medicine, Journal Year: 2022, Volume and Issue: 37(4), P. 426 - 443

Published: Dec. 15, 2022

Background: People who use drugs with life-limiting illnesses experience substantial barriers to accessing palliative care. Demand for care is expected increase during communicable disease epidemics and pandemics. Understanding how pandemics affect people important from a service delivery perspective reducing population health inequities. Aim: To explore what known about pandemics, care, drugs. Design: Scoping review. Data sources: We searched six bibliographic databases inception April 2021 as well the grey literature. included English French records access, programs, policies guidelines ⩾18 years old Results: Forty-four articles were in our analysis. identified limited knowledge other than HIV/AIDS. Through thematic synthesis of records, we generated following themes: enablers organizational barriers, structural inequity, access opioids psychoactive substances, stigma. Conclusions: Our findings underscore need further research best provide suggest four ways that systems can be better prepared help alleviate limit support provision high-quality future

Language: Английский

The impact of the COVID-19 pandemic on people who use drugs in three Canadian cities: a cross-sectional analysis DOI Creative Commons
Sanjana Mitra, Zachary Bouck, Sarah Larney

et al.

Harm Reduction Journal, Journal Year: 2024, Volume and Issue: 21(1)

Published: May 16, 2024

Abstract Background The COVID-19 pandemic had a disproportionate impact on the health and wellbeing of people who use drugs (PWUD) in Canada. However less is known about jurisdictional commonalities differences exposure impacts pandemic-related restrictions competing social risks among PWUD living large urban centres. Methods Between May 2020 March 2021, leveraging infrastructure from ongoing cohorts PWUD, we surveyed 1,025 participants Vancouver ( n = 640), Toronto 158), Montreal 227), Canada to describe basic, health, harm reduction needs. Results Among participants, awareness protective measures was high; however, between 10 24% each city-specific sample reported being unable self-isolate. Overall, 3–19% experiencing homelessness after onset pandemic, while 20–41% that they went hungry more often than usual. Furthermore, 8–33% an overdose during though most indicated no change frequency compared pre-pandemic period. Most receiving opioid agonist therapy past six months treatment continuity (87–93%), 32% 22% missing doses due service disruptions. There were some reports difficulty accessing supervised consumption sites all three sites, drug checking services Vancouver. Conclusion Findings suggest experienced difficulties meeting essential needs pandemic. These findings can inform preparedness planning for future public emergencies.

Language: Английский

Citations

6
Endogenous opiates and behavior: 2022 DOI
Richard J. Bodnar

Peptides, Journal Year: 2023, Volume and Issue: 169, P. 171095 - 171095

Published: Sept. 12, 2023

Language: Английский

Citations

13
Impacts of the COVID-19 pandemic on supervised consumption service delivery in Vancouver and Surrey, Canada from the perspective of service providers DOI Creative Commons
Tyson Singh Kelsall,

Michelle Olding,

Tara Myketiak

et al.

Deleted Journal, Journal Year: 2025, Volume and Issue: 22(1)

Published: Jan. 20, 2025

Following the onset of COVID-19 pandemic, an ever-increasing number people have died from toxic drug supply in Canada. Emerging evidence suggests that reduced access to harm reduction services has been a contributing factor. However, precise impacts pandemic on supervised consumption service (SCS) delivery not well characterized. The present study sought explore SCS Vancouver and Surrey, Between October 2021 March 2022, in-depth, semi-structured interviews were conducted with staff two SCS: SafePoint Surrey (n = 12) Insite 9). Thematic analysis focused key changes after emergence focus associated challenges emergent responses. Participants described as: capacity restrictions hindering compromising care quality; exclusion frontline perspectives evolving policy practice decision-making; intensified power dynamics between users; modified overdose response procedures, combined rise complex presentations, undermining accessibility quality. Emergent responses these included: collective organizing for policy; individual non-compliance emerging policies; experiencing burnout their roles. This highlights how COVID-19-related produced users, while identifying strategies employed by address challenges. Additionally, findings point opportunities improve who use drugs during intersecting public health crises.

Language: Английский

Citations

0
Characteristics of supervised injection site clients and factors associated with requiring overdose intervention, Montreal, Canada, 2018–2022 DOI Creative Commons
Camille Zolopa, Thomas D. Brothers,

Pascale Leclerc

et al.

International Journal of Drug Policy, Journal Year: 2025, Volume and Issue: 137, P. 104711 - 104711

Published: Jan. 21, 2025

Language: Английский

Citations

0
The effect of Montreal’s supervised consumption sites on injection-related infections among people who inject drugs: An interrupted time series DOI Creative Commons
Jihoon Lim, Dimitra Panagiotoglou

PLoS ONE, Journal Year: 2024, Volume and Issue: 19(8), P. e0308482 - e0308482

Published: Aug. 27, 2024

Background Between June and November 2017, four supervised consumption sites (SCS) began operating in Montreal, Quebec. Earlier studies on SCS focused examining their effects blood-borne viral infections overdose mortality. Our objective was to examine the effect of Montreal’s incidence, health service use outcomes injection-related (IRI) people who inject drugs. Methods We used Quebec’s provincial administrative data identify drugs Montreal calculated incidence IRI this population between December 2014 2019. conducted a retrospective, population-based interrupted time series estimate monthly rates IRI-related hospitalizations, emergency department (ED) visits, physician also examined average length hospitalizations involving surgery. Results The age 41.84 years, 66.41% were male. After implementation SCS, there positive level change (0.97; 95% confidence interval [CI]: 0.26, 1.68) for IRI. There significant post-intervention decline hospitalization trends (-0.05; CI: -0.08, -0.02), with modest trend changes ED visits (-0.02; -0.05, 0.02). However, (0.72; -3.85, 5.29) (0.06; -0.23, 0.34) remained limited. had no but decreasing surgery (-0.03; -0.06, 0.00). Conclusion Following opening moderate rate treat IRI, impact These findings suggest that may mitigate more serious complicated over time.

Language: Английский

Citations

3
Trends in toxicological findings in unintentional opioid or stimulant toxicity deaths in Québec, Canada, 2012–2021: Has Québec entered a new era of drug‐related deaths? DOI Creative Commons

Uyen Do,

Paul‐André Perron,

Julie Bruneau

et al.

Drug and Alcohol Review, Journal Year: 2024, Volume and Issue: 43(6), P. 1613 - 1624

Published: Aug. 6, 2024

We aimed to describe rates and toxicological findings of unintentional opioid stimulant toxicity deaths, 2012-2021.

Language: Английский

Citations

2
Reflections on editing the International Journal of Drug Policy: The limits and power of research evidence DOI
Alison Ritter

International Journal of Drug Policy, Journal Year: 2024, Volume and Issue: 127, P. 104421 - 104421

Published: April 12, 2024

Language: Английский

Citations

1
Palliative care for people who use drugs during communicable disease epidemics and pandemics: A scoping review on access, policies, and programs and guidelines DOI
Daniel Z. Buchman,

Samantha Lo,

Philip Q. Ding

et al.

Palliative Medicine, Journal Year: 2022, Volume and Issue: 37(4), P. 426 - 443

Published: Dec. 15, 2022

Background: People who use drugs with life-limiting illnesses experience substantial barriers to accessing palliative care. Demand for care is expected increase during communicable disease epidemics and pandemics. Understanding how pandemics affect people important from a service delivery perspective reducing population health inequities. Aim: To explore what known about pandemics, care, drugs. Design: Scoping review. Data sources: We searched six bibliographic databases inception April 2021 as well the grey literature. included English French records access, programs, policies guidelines ⩾18 years old Results: Forty-four articles were in our analysis. identified limited knowledge other than HIV/AIDS. Through thematic synthesis of records, we generated following themes: enablers organizational barriers, structural inequity, access opioids psychoactive substances, stigma. Conclusions: Our findings underscore need further research best provide suggest four ways that systems can be better prepared help alleviate limit support provision high-quality future

Language: Английский

Citations

1